U.S. Expresses Concern Over India’s Proposal To Allow More Generic Drug Production
Reuters: U.S. fears for patents on next-generation drugs in India
“The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent…” (Busvine/Siddiqui, 3/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.